INTRAHEPATIC HEPATITIS C REPLICATION IN PATIENTS WITH AND WITHOUT HIV INFECTION
丙型肝炎在感染和未感染 HIV 的患者中的肝内复制
基本信息
- 批准号:7379313
- 负责人:
- 金额:$ 0.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. HCV-infected individuals who are co-infected with HIV have a significantly increased risk of cirrhosis and liver failure when compared to those who are HIV-negative. Furthermore, severe HIV-related immunodeficiency appears to be an independent predictor of advanced liver disease. We hypothesize that immunodeficiency is associated with enhanced HCV replication, and that increased HCV replication is in part responsible for the advanced liver disease seen in co-infected patients. In order to test these hypotheses, we will utilize a novel, strand-specific in situ hybridization assay for HCV RNA in liver tissue from a well-characterized cohort of HCV-infected subjects with and without HIV co-infection.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。与HIV阴性者相比,HCV感染者合并HIV感染者发生肝硬化和肝功能衰竭的风险显著增加。此外,严重的HIV相关免疫缺陷似乎是晚期肝病的独立预测因子。我们假设免疫缺陷与HCV复制增强有关,而HCV复制增强是合并感染患者中晚期肝病的部分原因。为了检验这些假设,我们将利用一种新的,链特异性原位杂交检测HCV RNA在肝组织中的一个良好的特征队列的HCV感染的受试者与艾滋病毒合并感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET C SHUHART其他文献
MARGARET C SHUHART的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET C SHUHART', 18)}}的其他基金
INTRAHEPATIC HEPATITIS C REPLICATION IN PTS WITH AND WITHOUT HIV INFECTION
感染和未感染 HIV 的患者中丙型肝炎的肝内复制
- 批准号:
7603431 - 财政年份:2007
- 资助金额:
$ 0.69万 - 项目类别:
THE EFFECT OF HAART ON HCV REPLICATION AND IMMUNE RESPONSE TO HCV
HAART 对 HCV 复制和 HCV 免疫反应的影响
- 批准号:
7379318 - 财政年份:2006
- 资助金额:
$ 0.69万 - 项目类别:
THE EFFECT OF HAART ON HCV REPLICATION AND IMMUNE RESPONSE TO HCV
HAART 对 HCV 复制和 HCV 免疫反应的影响
- 批准号:
7198816 - 财政年份:2005
- 资助金额:
$ 0.69万 - 项目类别:
INTRAHEPATIC HEPATITIS C REPLICATION IN PTS WITH AND WITHOUT HIV INFECTION
感染和未感染 HIV 的患者中丙型肝炎的肝内复制
- 批准号:
7198810 - 财政年份:2005
- 资助金额:
$ 0.69万 - 项目类别:
THE EFFECT OF HAART ON HCV REPLICATION AND IMMUNE RESPONSE TO HCV
HAART 对 HCV 复制和 HCV 免疫反应的影响
- 批准号:
6974528 - 财政年份:2004
- 资助金额:
$ 0.69万 - 项目类别:
Intrahepatic hepatitis C replication in pts with and without HIV Infection
感染和未感染 HIV 的患者的肝内丙型肝炎复制
- 批准号:
6974517 - 财政年份:2004
- 资助金额:
$ 0.69万 - 项目类别:
相似国自然基金
新生期接种乙肝疫苗(hepatitis B vaccine,HBV)影响小鼠情绪相关行为及其机制研究
- 批准号:31600836
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Does cccDNA depletion by complete blockage of HBV replication result in a cure for hepatitis B? -Elucidation using PXB mice model-
通过完全阻断 HBV 复制来消除 cccDNA 是否可以治愈乙型肝炎?
- 批准号:
23H02954 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Exploring the role of LLPS of nuclear proteins in the replication of Hepatitis B viru
探索核蛋白 LLPS 在乙型肝炎病毒复制中的作用
- 批准号:
23H02425 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of the new control method to inhibit the hepatocellular carcinogenesis process following HBV replication for chronic hepatitis B
开发新的控制方法来抑制慢性乙型肝炎病毒复制后的肝细胞癌变过程
- 批准号:
23KJ1616 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Elucidation of host factors and the associated pathways responsible for cellular permissiveness to hepatitis E virus replication and identification of the potential inhibitors
阐明导致细胞允许戊型肝炎病毒复制的宿主因素和相关途径以及潜在抑制剂的鉴定
- 批准号:
22K15478 - 财政年份:2022
- 资助金额:
$ 0.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of parvovirus replication in viral hepatitis
病毒性肝炎中细小病毒的复制机制
- 批准号:
10683224 - 财政年份:2022
- 资助金额:
$ 0.69万 - 项目类别:
Mechanisms of parvovirus replication in viral hepatitis
病毒性肝炎中细小病毒的复制机制
- 批准号:
10525014 - 财政年份:2022
- 资助金额:
$ 0.69万 - 项目类别:
Small molecule inhibitors of HBx that decrease hepatitis B virus replication
减少乙型肝炎病毒复制的 HBx 小分子抑制剂
- 批准号:
10284389 - 财政年份:2021
- 资助金额:
$ 0.69万 - 项目类别:
Small molecule inhibitors of HBx that decrease hepatitis B virus replication
减少乙型肝炎病毒复制的 HBx 小分子抑制剂
- 批准号:
10451632 - 财政年份:2021
- 资助金额:
$ 0.69万 - 项目类别:
Elucidation of virus multiplication mechanism by a novel hepatitis B virus replication system using stabilized polymerase
使用稳定聚合酶的新型乙型肝炎病毒复制系统阐明病毒复制机制
- 批准号:
20K07515 - 财政年份:2020
- 资助金额:
$ 0.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of hepatitis B virus replication by a microRNA inhibitor
microRNA 抑制剂抑制乙型肝炎病毒复制
- 批准号:
20K07531 - 财政年份:2020
- 资助金额:
$ 0.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)